Byungheon Lee

Byungheon Lee

Auto-generated profile, based on publicly available information

Byungheon Lee

Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Biomaterials
Verified
Journal Article
Closed access
GGGowri Rangaswamy Gunassekaran
Gowri Rangaswamy Gunassekaran
SVSri Murugan Poongkavithai Vadevoo
Sri Murugan Poongkavithai Vadevoo
MBMoon-Chang Baek
Moon-Chang Baek
BLByungheon Lee
Byungheon Lee

1 June 2023 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
SVSri Murugan Poongkavithai Vadevoo
Sri Murugan Poongkavithai Vadevoo
SGSmriti Gurung
Smriti Gurung
HLHyun-Su Lee
Hyun-Su Lee
GGGowri Rangaswamy Gunassekaran
Gowri Rangaswamy Gunassekaran
SLSeok-Min Lee
Seok-Min Lee
BLByungheon Lee
Byungheon Lee
Peptides exhibit lower affinity and a shorter half-life in the body than antibodies. Conversely, peptides demonstrate higher efficiency in tissue penetration and cell internalization than antibodies. Regardless of the pros and cons of peptides, they have been used as tumor-homing ligands for delivering carriers (such as nanoparticles, extracellular vesicles, and cells) and cargoes (such as cytotoxic peptides and radioisotopes) to tumors. Additionally, tumor-homing peptides have been conjugated with cargoes such as small-molecule or chemotherapeutic drugs via linkers to synthesize peptide–drug conjugates. In addition, peptides selectively bind to cell surface receptors and proteins, such as immune checkpoints, receptor kinases, and hormone receptors, subsequently blocking their biological activity or serving as hormone analogs. Furthermore, peptides internalized into cells bind to intracellular proteins and interfere with protein–protein interactions. Thus, peptides demonstrate great application potential as multifunctional players in cancer therapy.

9 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SVSri Murugan Poongkavithai Vadevoo
Sri Murugan Poongkavithai Vadevoo
GGGowri Rangaswamy Gunassekaran
Gowri Rangaswamy Gunassekaran
CLChaeEun Lee
ChaeEun Lee
NLNaHye Lee
NaHye Lee
JLJiyoun Lee
Jiyoun Lee
BLByungheon Lee
Byungheon Lee
Expression and function of odorant receptors (ORs), which account for more than 50% of G protein–coupled receptors, are being increasingly reported in nonolfactory sites. However, ORs that can be targeted by drugs to treat diseases remain poorly identified. Tumor-derived lactate plays a crucial role in multiple signaling pathways leading to generation of tumor-associated macrophages (TAMs). In this study, we hypothesized that the macrophage OR Olfr78 functions as a lactate sensor and shapes the macrophage–tumor axis. Using Olfr78+/+ and Olfr78−/− bone marrow–derived macrophages with or without exogenous Olfr78 expression, we demonstrated that Olfr78 sensed tumor-derived lactate, which was the main factor in tumor-conditioned media responsible for generation of protumoral M2-TAMs. Olfr78 functioned together with Gpr132 to mediate lactate-induced generation of protumoral M2-TAMs. In addition, syngeneic Olfr78-deficient mice exhibited reduced tumor progression and metastasis together with an increased anti- versus protumoral immune cell population. We propose that the Olfr78–lactate interaction is a therapeutic target to reduce and prevent tumor progression and metastasis. Significance Expression and function of odorant receptors (ORs) are being increasingly reported in nonolfactory sites. However, ORs that can be targeted by drugs to treat diseases remain poorly identified. Here, we hypothesized that the macrophage OR Olfr78 functions as a tumor-derived lactate sensor and shapes the macrophage–tumor axis. Olfr78 and the G protein–coupled receptor Gpr132 form a heterodimer that senses lactate in the tumor microenvironment, leading to generation of tumor-associated macrophages with a protumoral M2 phenotype, which promotes tumor progression and metastasis. Our findings suggest an alternative strategy for cancer treatment, namely targeting the interaction between tumor-derived metabolites and ORs.

1 July 2020 in Biomaterials
Verified
Journal Article
Closed access
SGSmriti Gurung
Smriti Gurung
FKFatima Khan
Fatima Khan
GGGowri Rangaswamy Gunassekaran
Gowri Rangaswamy Gunassekaran
JYJae Do Yoo
Jae Do Yoo
SVSri Murugan Poongkavithai Vadevoo
Sri Murugan Poongkavithai Vadevoo
BLByungheon Lee
Byungheon Lee

30 October 2008 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
HHHai‐Yan Hong
Hai‐Yan Hong
HLHwa Young Lee
Hwa Young Lee
WKWonjung Kwak
Wonjung Kwak
JYJeongsoo Yoo
Jeongsoo Yoo
MNMoon‐Hee Na
Moon‐Hee Na
BLByung‐Heon Lee
Byung‐Heon Lee
Imaging or drug delivery tools for atherosclerosis based on the plaque biology are still insufficient. Here, we attempted to identify peptides that selectively home to atherosclerotic plaques using phage display. A phage library containing random peptides was ex viv screened for binding to human atheroma tissues. After three to four rounds of selection, the DNA inserts of phage clones wer sequenced. A peptide sequence, CRKRLDRNC, was the most frequently occurring one. Intravenously injected phage displaying the CRKRLDRNC peptide was observed to home to atherosclerotic aortic tissues of low‐density lipoprotein receptor‐deficient (Ldlr−/–) mice at higher levels than to normal aortic tissues of wild‐type mice. Moreover, a fluorescein‐ or radioisotope‐conjugated synthetic CRKRLDRNC peptide, but not a control peptide, homed in vivo to atherosclerotic plaques in Ldlr−/– mice, while homing of the peptide to other organs such as brain was minimal. The homing peptide co‐localized with endothelial cells, macrophages and smooth muscle cells a mouse and human atherosclerotic plaques. Homology search revealed that the CRKRLDRNC peptide shares a motif of interleukin‐receptor (IL‐4) that is critical for binding to its receptor. The peptide indeed co‐localized with IL‐4 receptor (IL‐4R) at atherosclerotic plaques. Moreover, the peptide bound to cultured cells expressing IL‐4R on the cell surface and the binding was inhibited by the knock‐down of IL‐4R. These results show that the CRKRLDRNC peptide homes to atherosclerotic plaques through binding to IL‐4R as its target and may be a useful tool for selective drug delivery and molecular imaging of atherosclerosis.

1 August 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
HJHyun-Kyung Jung
Hyun-Kyung Jung
SKSoyoun Kim
Soyoun Kim
RPRang-Woon Park
Rang-Woon Park
JPJae-Yong Park
Jae-Yong Park
IKIn-San Kim
In-San Kim
BLByungheon Lee
Byungheon Lee